OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efferocytosis in the tumor microenvironment
Thomas A. Werfel, Rebecca S. Cook
Seminars in Immunopathology (2018) Vol. 40, Iss. 6, pp. 545-554
Open Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

Gasdermin E suppresses tumour growth by activating anti-tumour immunity
Zhibin Zhang, Ying Zhang, Shiyu Xia, et al.
Nature (2020) Vol. 579, Iss. 7799, pp. 415-420
Open Access | Times Cited: 1278

The clearance of dead cells by efferocytosis
Emilio Boada-Romero, Jennifer Martinez, Bradlee L. Heckmann, et al.
Nature Reviews Molecular Cell Biology (2020) Vol. 21, Iss. 7, pp. 398-414
Open Access | Times Cited: 575

Pyroptosis: a new paradigm of cell death for fighting against cancer
Yixin Tan, Quanzhu Chen, Xiaoling Li, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 356

Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment
K. Myers, Sarah R. Amend, Kenneth J. Pienta
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 334

Pyroptosis, metabolism, and tumor immune microenvironment
Tiantian Du, Jie Gao, Peilong Li, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 8
Open Access | Times Cited: 223

Harnessing anti‐tumor and tumor‐tropism functions of macrophages via nanotechnology for tumor immunotherapy
Yanhui Zheng, Yaobao Han, Qiao Sun, et al.
Exploration (2022) Vol. 2, Iss. 3
Open Access | Times Cited: 118

Nanoparticle‐Based Photothermal Therapy for Breast Cancer Noninvasive Treatment
Yao Xiong, Yan Rao, Jiawei Hu, et al.
Advanced Materials (2023)
Closed Access | Times Cited: 83

Efferocytosis and Its Role in Inflammatory Disorders
Yun Ge, Man Huang, Yong-ming Yao
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 75

Single-cell RNA-sequencing reveals radiochemotherapy-induced innate immune activation and MHC-II upregulation in cervical cancer
Chao Liu, Xiaohui Li, Qingyu Huang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 54

Nanomedicines for an Enhanced Immunogenic Cell Death-Based In Situ Cancer Vaccination Response
Caiyan Zhao, Changrong Wang, Wenbo Shan, et al.
Accounts of Chemical Research (2024) Vol. 57, Iss. 6, pp. 905-918
Closed Access | Times Cited: 21

Immunomodulation of wound healing leading to efferocytosis
Yun Zhao, Minxiong Li, Jiayi Mao, et al.
Smart Medicine (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 20

NAMPT‐Driven M2 Polarization of Tumor‐Associated Macrophages Leads to an Immunosuppressive Microenvironment in Colorectal Cancer
Sun Mi Hong, A‐Yeon Lee, Byeong‐Ju Kim, et al.
Advanced Science (2024) Vol. 11, Iss. 14
Open Access | Times Cited: 17

Macrophage‐Mediated Tumor Cell Phagocytosis: Opportunity for Nanomedicine Intervention
Xuefei Zhou, Xiangrui Liu, Leaf Huang
Advanced Functional Materials (2020) Vol. 31, Iss. 5
Open Access | Times Cited: 114

Knocking ’em Dead: Pore-Forming Proteins in Immune Defense
Xing Liu, Judy Lieberman
Annual Review of Immunology (2020) Vol. 38, Iss. 1, pp. 455-485
Open Access | Times Cited: 93

MERTK in cancer therapy: Targeting the receptor tyrosine kinase in tumor cells and the immune system
Justus M. Huelse, Diana Fridlyand, Shelton Earp, et al.
Pharmacology & Therapeutics (2020) Vol. 213, pp. 107577-107577
Open Access | Times Cited: 71

Tumor-associated macrophages are shaped by intratumoral high potassium via Kir2.1
Sheng Chen, Wenyu Cui, Zhexu Chi, et al.
Cell Metabolism (2022) Vol. 34, Iss. 11, pp. 1843-1859.e11
Open Access | Times Cited: 62

Thymosin α-1 Reverses M2 Polarization of Tumor-Associated Macrophages during Efferocytosis
Yiting Wei, Xu-ru Wang, Chunguang Yan, et al.
Cancer Research (2022) Vol. 82, Iss. 10, pp. 1991-2002
Open Access | Times Cited: 41

Macrophage efferocytosis in health and disease
Shokufeh Razi, Javad Yaghmoorian Khojini, Fateme Kargarijam, et al.
Cell Biochemistry and Function (2023) Vol. 41, Iss. 2, pp. 152-165
Closed Access | Times Cited: 36

Cancer Immunotherapy Based on Cell Membrane‐Coated Nanocomposites Augmenting cGAS/STING Activation by Efferocytosis Blockade
Zhian Chen, Zhenhao Li, Huilin Huang, et al.
Small (2023) Vol. 19, Iss. 43
Closed Access | Times Cited: 31

Advancements in Photothermal Therapy Using Near-Infrared Light for Bone Tumors
Mengzhang Xie, Taojun Gong, Yitian Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4139-4139
Open Access | Times Cited: 13

Regulation of efferocytosis as a novel cancer therapy
Yunxiang Zhou, Yihan Yao, Yongchuan Deng, et al.
Cell Communication and Signaling (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 64

Apoptosis – Fueling the oncogenic fire
Camila Castillo Ferrer, Kévin Berthenet, Gabriel Ichim
FEBS Journal (2020) Vol. 288, Iss. 15, pp. 4445-4463
Open Access | Times Cited: 53

First we eat, then we do everything else: The dynamic metabolic regulation of efferocytosis
Alissa Trzeciak, Yating Wang, Justin S. A. Perry
Cell Metabolism (2021) Vol. 33, Iss. 11, pp. 2126-2141
Open Access | Times Cited: 53

DCision-making in tumors governs T cell anti-tumor immunity
Francesca Alfei, Ping‐Chih Ho, Wan‐Lin Lo
Oncogene (2021) Vol. 40, Iss. 34, pp. 5253-5261
Open Access | Times Cited: 43

Specialized Pro-Resolving Mediators Mitigate Cancer-Related Inflammation: Role of Tumor-Associated Macrophages and Therapeutic Opportunities
Margot Lavy, Vanessa Gauttier, Nicolas Poirier, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 42

Page 1 - Next Page

Scroll to top